Home / Inspections / 1244256

FDA Inspection 1244256 — Avara Liscate Pharmaceutical Services SPA

Avara Liscate Pharmaceutical Services SPA — FEI 3004640070

The FDA completed an inspection of Avara Liscate Pharmaceutical Services SPA on June 9, 2023 in Liscate. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 9, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Liscate (Italy)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1323162 (VAI Fri Feb 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1192062 (VAI Tue Dec 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1102380 (VAI Fri Sep 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1000021 (VAI Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 881210 (OAI Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources